Clinical Trials for Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Find clinical trials for accelerated phase chronic myelogenous leukemia, bcr-abl1 positive. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

NCT ID: NCT03263572

This clinical trial is studying a combination of four medications—blinatumomab, methotrexate, cytarabine, and ponatinib—to see how well they work for patients with Philadelphia chromosome-positive ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Personalized NK Cell Therapy in CBT

NCT ID: NCT02727803

This clinical trial is looking at a new treatment called personalized natural killer (NK) cell therapy for patients with certain types of blood cancers, including leukemia, lymphoma, and myelodyspl...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions